Stay updated on AMG 133 Dose-ranging in Overweight Adults Clinical Trial
Sign up to get notified when there's something new on the AMG 133 Dose-ranging in Overweight Adults Clinical Trial page.

Latest updates to the AMG 133 Dose-ranging in Overweight Adults Clinical Trial page
- Check3 days agoChange DetectedThe record now presents the completed Phase 2 AMG 133 study details, including its design, eligibility criteria, treatment arms, outcome measures, and 78 locations. It also provides publication, study-history, and individual-participant-data sharing information.SummaryDifference94%

- Check10 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 error.SummaryDifference0.2%

- Check17 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check24 days agoChange DetectedThe footer revision indicator changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe study record area displays a 403 Forbidden message with a Home link instead of study details.SummaryDifference0.5%

Stay in the know with updates to AMG 133 Dose-ranging in Overweight Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMG 133 Dose-ranging in Overweight Adults Clinical Trial page.